CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
US Bahasa Indonesia
Negara • United States
    Entitas • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan SAB Biotherapeutics, Inc. - SABS CFD

    0.91
    5.81%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.06
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.025457%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.003235%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 0.86
    Open* 0.9
    1-Year Change* -52.38%
    Day's Range* 0.87 - 0.91
    52 wk Range 0.37-2.19
    Average Volume (10 days) 58.20K
    Average Volume (3 months) 28.52M
    Market Cap 46.19M
    P/E Ratio -100.00K
    Shares Outstanding 50.40M
    Revenue 12.68M
    EPS -0.60
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date Aug 8, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Jun 2, 2023 0.86 0.00 0.00% 0.86 0.88 0.86
    Jun 1, 2023 0.87 0.00 0.00% 0.87 0.89 0.85
    May 31, 2023 0.85 0.02 2.41% 0.83 0.88 0.83
    May 30, 2023 0.87 0.05 6.10% 0.82 0.88 0.82
    May 26, 2023 0.84 0.01 1.20% 0.83 0.86 0.82
    May 25, 2023 0.82 -0.04 -4.65% 0.86 0.86 0.82
    May 24, 2023 0.87 0.04 4.82% 0.83 0.87 0.83
    May 23, 2023 0.84 -0.02 -2.33% 0.86 0.87 0.81
    May 22, 2023 0.87 0.06 7.41% 0.81 0.90 0.80
    May 19, 2023 0.79 -0.03 -3.66% 0.82 0.83 0.79
    May 18, 2023 0.83 0.03 3.75% 0.80 0.85 0.80
    May 17, 2023 0.82 0.05 6.49% 0.77 0.83 0.77
    May 16, 2023 0.75 -0.08 -9.64% 0.83 0.83 0.73
    May 15, 2023 0.85 -0.01 -1.16% 0.86 0.90 0.84
    May 12, 2023 0.90 -0.03 -3.23% 0.93 0.95 0.85
    May 11, 2023 0.90 -0.02 -2.17% 0.92 0.94 0.89
    May 10, 2023 0.93 0.05 5.68% 0.88 0.93 0.88
    May 9, 2023 0.89 -0.01 -1.11% 0.90 0.95 0.86
    May 8, 2023 0.94 0.10 11.90% 0.84 0.97 0.82
    May 5, 2023 0.84 0.03 3.70% 0.81 0.86 0.79

    SAB Biotherapeutics, Inc. Events

    Time (UTC) Country Event
    Wednesday, June 14, 2023

    Time (UTC)

    18:30

    Country

    US

    Event

    SAB Biotherapeutics Inc R&D Day
    SAB Biotherapeutics Inc R&D Day

    Forecast

    -

    Previous

    -
    Thursday, July 6, 2023

    Time (UTC)

    14:00

    Country

    US

    Event

    SAB Biotherapeutics Inc Annual Shareholders Meeting
    SAB Biotherapeutics Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Tuesday, August 8, 2023

    Time (UTC)

    12:30

    Country

    US

    Event

    Q2 2023 SAB Biotherapeutics Inc Earnings Release
    Q2 2023 SAB Biotherapeutics Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 13, 2023

    Time (UTC)

    13:30

    Country

    US

    Event

    Q3 2023 SAB Biotherapeutics Inc Earnings Release
    Q3 2023 SAB Biotherapeutics Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020
    Total revenue 23.9042 60.8761 55.2378
    Revenue 23.9042 60.8761 55.2378
    Total Operating Expense 52.8218 73.6037 34.681
    Selling/General/Admin. Expenses, Total 16.3833 17.0857 6.7723
    Research & Development 36.0325 57.1836 27.9087
    Unusual Expense (Income) 0 -0.6656 0
    Operating Income -28.9176 -12.7276 20.5568
    Interest Income (Expense), Net Non-Operating 10.1687 -4.42241 -0.44302
    Other, Net 0.03375 0.00549 0.004
    Net Income Before Taxes -18.7152 -17.1445 20.1178
    Net Income After Taxes -18.7408 -17.1445 20.1178
    Net Income Before Extra. Items -18.7408 -17.1445 20.1178
    Net Income -18.7408 -17.1445 20.1178
    Income Available to Common Excl. Extra. Items -18.7408 -17.1445 20.1178
    Income Available to Common Incl. Extra. Items -18.7408 -17.1445 20.1178
    Diluted Net Income -18.7408 -17.1445 20.1178
    Diluted Weighted Average Shares 43.525 42.9551 27.0115
    Diluted EPS Excluding Extraordinary Items -0.43058 -0.39913 0.74479
    Dividends per Share - Common Stock Primary Issue 0
    Diluted Normalized EPS -0.43058 -0.41462 0.74479
    Depreciation / Amortization 0.284
    Interest Expense (Income) - Net Operating 0.122
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 0.5811 2.16087 3.58971 18.1536 11.8031
    Total Operating Expense 7.98311 10.0209 11.397 31.4039 18.5104
    Other Operating Expenses, Total -0.092
    Operating Income -7.40201 -7.86001 -7.80731 -13.2503 -6.70734
    Interest Income (Expense), Net Non-Operating 0.04818 -0.02118 0.72972 9.46015 7.78549
    Other, Net 0.03223 0.00153 0
    Net Income Before Taxes -7.35382 -7.84897 -7.07607 -3.79014 1.07814
    Net Income After Taxes -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    Net Income Before Extra. Items -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    Net Income -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    Income Available to Common Excl. Extra. Items -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    Income Available to Common Incl. Extra. Items -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    Diluted Net Income -7.35382 -7.8746 -7.07607 -3.79014 0.98586
    Diluted Weighted Average Shares 50.397 44.9728 43.0309 43.0366 43.1133
    Diluted EPS Excluding Extraordinary Items -0.14592 -0.1751 -0.16444 -0.08807 0.02287
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.14592 -0.1751 -0.16444 -0.08807 0.02287
    Revenue 0.5811 2.16087 3.58971 18.1536 11.8031
    Selling/General/Admin. Expenses, Total 3.44739 2.88277 4.04405 9.45647 5.18607
    Research & Development 4.44172 7.04411 7.25698 21.7314 13.2113
    Unusual Expense (Income) 0 0 0 0
    Depreciation / Amortization 0.025 0.186 0.025 0.073 0.041
    Interest Expense (Income) - Net Operating 0.069 0.071 0.143 0.072
    • Annual
    • Quarterly
    2022 2021 2020
    Total Current Assets 22.0975 50.192 34.455
    Cash and Short Term Investments 15.0469 33.2067 12.6104
    Cash & Equivalents 15.0469 33.2067 12.6104
    Total Receivables, Net 5.55658 8.01071 20.5695
    Accounts Receivable - Trade, Net 5.55658 8.01071 20.5695
    Prepaid Expenses 1.49398 2.63622 1.27513
    Other Current Assets, Total 0 6.33831 0
    Total Assets 50.9049 81.1409 56.5379
    Property/Plant/Equipment, Total - Net 28.3398 30.949 22.0829
    Property/Plant/Equipment, Total - Gross 34.6183 34.169 23.8501
    Accumulated Depreciation, Total -6.27852 -3.22002 -1.76719
    Total Current Liabilities 14.9933 26.4553 11.0617
    Accounts Payable 3.67912 4.45853 7.38236
    Accrued Expenses 10.3588 13.382 2.82914
    Notes Payable/Short Term Debt 0 0 0
    Current Port. of LT Debt/Capital Leases 0.90545 1.95777 0.73345
    Other Current Liabilities, Total 0.05 6.65692 0.11678
    Total Liabilities 19.8468 42.591 17.5301
    Total Long Term Debt 4.17129 3.76243 4.09559
    Long Term Debt 0.54164 0 0.17204
    Capital Lease Obligations 3.62964 3.76243 3.92355
    Other Liabilities, Total 0.68216 12.3733 2.37278
    Total Equity 31.0581 38.5499 39.0078
    Common Stock 0.00509 0.00435 0.0026
    Additional Paid-In Capital 84.4441 67.6745 50.9897
    Retained Earnings (Accumulated Deficit) -47.8698 -29.129 -11.9844
    Total Liabilities & Shareholders’ Equity 50.9049 81.1409 56.5379
    Total Common Shares Outstanding 50.3943 43.4873 25.9734
    Other Long Term Assets, Total 0.46769 0
    Treasury Stock - Common -5.52125 0
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 15.032 22.0975 22.1821 27.7505 36.1697
    Cash and Short Term Investments 13.0601 15.0469 8.33219 16.6165 22.4084
    Cash
    Prepaid Expenses 1.20878 1.49398 0.90787 1.52138 1.97491
    Total Assets 42.672 50.9049 52.5075 59.1549 67.4725
    Long Term Investments
    Other Long Term Assets, Total 0.434 0.46769 0.50139 0.53508
    Total Current Liabilities 13.6657 14.9933 17.1012 16.1372 18.2559
    Accrued Expenses 8.65427 10.3588 11.3686 10.9954 12.9613
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 18.2695 19.8468 21.8841 22.0336 26.2142
    Total Long Term Debt 4.13777 4.17129 3.66254 3.69483 3.72894
    Other Liabilities, Total 0.466 0.68216 1.12029 2.2016 4.22939
    Total Equity 24.4025 31.0581 30.6234 37.1213 41.2583
    Common Stock 0.00509 0.00509 0.00436 0.00436 0.00435
    Additional Paid-In Capital 85.1423 84.4441 76.1355 75.5572 74.9183
    Retained Earnings (Accumulated Deficit) -55.2236 -47.8698 -39.9952 -32.9191 -28.1431
    Total Liabilities & Shareholders’ Equity 42.672 50.9049 52.5075 59.1549 67.4725
    Total Common Shares Outstanding 50.3978 50.3943 43.0309 43.0309 42.9551
    Cash & Equivalents 13.0601 15.0469 8.33219 16.6165 22.4084
    Total Receivables, Net 0.76312 5.55658 12.942 9.61267 11.7864
    Accounts Receivable - Trade, Net 0.76312 5.55658 12.942 9.61267 11.7864
    Other Current Assets, Total 0 0 0 0
    Property/Plant/Equipment, Total - Net 27.206 28.3398 29.824 30.8693 31.3027
    Accounts Payable 1.44496 3.67912 5.48428 4.94358 4.98139
    Current Port. of LT Debt/Capital Leases 0.57729 0.90545 0.1659 0.16578 0.17091
    Other Current Liabilities, Total 2.9892 0.05 0.0825 0.0325 0.14228
    Long Term Debt 0.54164 0.54164
    Capital Lease Obligations 3.59613 3.62964 3.66254 3.69483 3.72894
    Property/Plant/Equipment, Total - Gross 34.383 34.6183 35.2037 35.3823 35.0665
    Accumulated Depreciation, Total -7.17698 -6.27852 -5.37971 -4.51296 -3.76377
    Treasury Stock - Common -5.52125 -5.52125 -5.52125 -5.52125 -5.52125
    • Annual
    • Quarterly
    2022 2021 2020
    Net income/Starting Line -18.7408 -17.1445 20.1178
    Cash From Operating Activities -23.4595 1.98687 10.0048
    Cash From Operating Activities 3.16943 1.48861 0.38314
    Non-Cash Items -7.65056 5.95965 1.45821
    Changes in Working Capital -0.23758 11.6831 -11.9543
    Cash From Investing Activities -2.09002 -10.9437 -12.7227
    Capital Expenditures -2.16641 -10.9437 -12.7317
    Other Investing Cash Flow Items, Total 0.07639 0.009
    Cash From Financing Activities 1.05141 35.8914 8.98232
    Issuance (Retirement) of Stock, Net 2.23652 34.347 10.5618
    Issuance (Retirement) of Debt, Net -1.18511 1.54444 -1.5795
    Net Change in Cash -24.4981 26.9346 6.26441
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -7.35382 -18.7408 -10.8662 -3.79013 0.98586
    Cash From Operating Activities -1.60572 -23.4595 -23.6762 -15.5026 -9.53773
    Non-Cash Items 0.63844 -7.65056 -8.23501 -8.05345 -6.92504
    Changes in Working Capital 4.21121 -0.23758 -6.84564 -5.04444 -4.32706
    Cash From Investing Activities -0.0213 -2.09002 -1.97227 -1.89377 -1.28093
    Other Investing Cash Flow Items, Total 0 0.07639 0.07639 0.07639 0.07639
    Cash From Financing Activities -0.35979 1.05141 -5.56433 -5.53216 -6.31795
    Financing Cash Flow Items
    Issuance (Retirement) of Stock, Net 0.00189 2.23652 -5.44427 -5.44428 -5.51342
    Issuance (Retirement) of Debt, Net -0.36168 -1.18511 -0.12005 -0.08788 -0.80453
    Net Change in Cash -1.98681 -24.4981 -31.2128 -22.9285 -17.1366
    Cash From Operating Activities 0.89845 3.16943 2.27062 1.38543 0.63624
    Capital Expenditures -0.0213 -2.16641 -2.04866 -1.97016 -1.35732
    Deferred Taxes 0 0.09228
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Sullivan (Eddie Joe) Individual Investor 10.3786 5230564 0 2023-05-12 LOW
    Hamilton (Christine E) Individual Investor 9.9074 4993090 0 2023-05-12 LOW
    Hamilton (Edward D.) Individual Investor 6.1675 3108270 0 2023-05-12
    First Premier Bank Bank and Trust 1.6023 807535 0 2023-03-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.3921 701584 0 2023-03-31 LOW
    Kropotova (Alexandra) Individual Investor 1.1409 575000 275000 2023-03-14
    Big Cypress Holdings, L.L.C. Corporation 1.0868 547698 0 2023-05-12
    Veritable, L.P. Investment Advisor/Hedge Fund 1.005 506513 0 2023-03-31 LOW
    Spragens (Jeffrey G.) Individual Investor 0.7837 394989 299002 2023-05-12 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5963 300529 0 2023-03-31 LOW
    First Manhattan Co. LLC Investment Advisor 0.5512 277777 277777 2023-03-31 LOW
    Reich (Samuel J.) Individual Investor 0.4127 208001 0 2023-05-12
    Warberg Asset Management LLC Hedge Fund 0.3525 177659 -192711 2023-03-31 HIGH
    IFAM Capital Investment Advisor 0.2972 149774 0 2023-03-31 LOW
    Meteora Capital LLC Hedge Fund 0.2669 134524 0 2023-03-31 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.2102 105959 1860 2023-03-31 LOW
    Bridgeway Capital Management, LLC Investment Advisor 0.1667 84000 0 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1612 81241 0 2023-03-31 LOW
    Hightower Advisors, LLC Investment Advisor 0.1458 73470 -2500 2023-03-31 LOW
    Link (David Charles) Individual Investor 0.1377 69410 0 2023-05-12 HIGH

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    535K+

    Trader

    87K+

    Klien aktif per bulan

    $113M+

    Volume investasi per bulan

    $64M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Biotechnology & Medical Research (NEC)

    2100 East 54Th Street North
    Suite 202
    SIOUX FALLS
    SOUTH DAKOTA 57104
    US

    Income Statement

    • Annual
    • Quarterly

    People also watch

    XRP/USD

    0.50 Price
    -8.600% 1D Chg, %
    Biaya inap posisi Long -0.0753%
    Biaya inap posisi short 0.0069%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.00446

    BTC/USD

    25,641.20 Price
    -6.240% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    US100

    14,554.90 Price
    -0.020% 1D Chg, %
    Biaya inap posisi Long -0.0255%
    Biaya inap posisi short 0.0032%
    Waktu biaya inap 21:00 (UTC)
    Spread 3.0

    Gold

    1,962.01 Price
    +0.700% 1D Chg, %
    Biaya inap posisi Long -0.0184%
    Biaya inap posisi short 0.0102%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 535.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda